145 related articles for article (PubMed ID: 20671585)
21. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
Kang HM; Kim YM; Koh HJ
Am J Ophthalmol; 2013 Mar; 155(3):438-447.e1. PubMed ID: 23218705
[TBL] [Abstract][Full Text] [Related]
22. Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters.
Lee WK; Kim KS; Kim W; Lee SB; Jeon S
Am J Ophthalmol; 2012 Aug; 154(2):355-365.e1. PubMed ID: 22541658
[TBL] [Abstract][Full Text] [Related]
23. [Polypoidal choroidal vasculopathy].
Yuzawa M
Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.
Sayanagi K; Gomi F; Sawa M; Ohji M; Tano Y
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1569-71. PubMed ID: 17437122
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
Lai TY; Lee GK; Luk FO; Lam DS
Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
[TBL] [Abstract][Full Text] [Related]
26. [Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy: long-term results].
Saito M; Nagayama D; Iida T
Nippon Ganka Gakkai Zasshi; 2009 Aug; 113(8):792-9. PubMed ID: 19715154
[TBL] [Abstract][Full Text] [Related]
27. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
Song MH; Ryu HW; Roh YJ
Ophthalmologica; 2011; 226(3):119-26. PubMed ID: 21757883
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy for polypoidal choroidal vasculopathy.
Chhablani JK
Am J Ophthalmol; 2010 Nov; 150(5):754-5; author reply 755. PubMed ID: 21036213
[No Abstract] [Full Text] [Related]
29. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
[TBL] [Abstract][Full Text] [Related]
30. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
Saito M; Iida T; Kano M
Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
[TBL] [Abstract][Full Text] [Related]
32. Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy.
Nakanishi H; Yamashiro K; Yamada R; Gotoh N; Hayashi H; Nakata I; Saito M; Iida T; Oishi A; Kurimoto Y; Matsuo K; Tajima K; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6183-7. PubMed ID: 20688737
[TBL] [Abstract][Full Text] [Related]
33. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
[TBL] [Abstract][Full Text] [Related]
34. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
Hussain N; Hussain A; Natarajan S
Indian J Ophthalmol; 2005 Jun; 53(2):101-4. PubMed ID: 15976464
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
Moon SW; Kim MS; Kim ES; Yu SY; Kwak HW
Ophthalmologica; 2011; 225(3):169-75. PubMed ID: 21273795
[TBL] [Abstract][Full Text] [Related]
36. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
[TBL] [Abstract][Full Text] [Related]
37. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
[TBL] [Abstract][Full Text] [Related]
38. Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.
Sakurada Y; Kubota T; Mabuchi F; Imasawa M; Tanabe N; Iijima H
Am J Ophthalmol; 2008 Jun; 145(6):1058-1062. PubMed ID: 18400199
[TBL] [Abstract][Full Text] [Related]
39. [Photodynamic therapy for polypoidal choroidal vasculopathy].
You J; Guo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):899-902. PubMed ID: 21946209
[TBL] [Abstract][Full Text] [Related]
40. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.
Tsujikawa A; Hirami Y; Nakanishi H; Ojima Y; Aikawa H; Tamura H; Otani A; Yoshimura N
Retina; 2007 Sep; 27(7):832-8. PubMed ID: 17891005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]